SP
LLY icon

Symmetry Partners’s Eli Lilly LLY Stock Holding History

Symmetry Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.99M Buy
3,325
+1,031
+45% +$1.05M 0.2% 48
2026
Q1 		$2.11M Sell
2,294
-14
-0.6% -$14.2K 0.12% 60
2025
Q4 		$2.48M Sell
2,308
-11
-0.5% -$10.5K 0.15% 56
2025
Q3 		$1.77M Buy
2,319
+380
+20% +$283K 0.19% 55
2025
Q2 		$1.51M Sell
1,939
-20
-1% -$15.5K 0.19% 54
2025
Q1 		$1.62M Sell
1,959
-57
-3% -$47.4K 0.23% 50
2024
Q4 		$1.56M Buy
2,016
+1,561
+343% +$1.29M 0.22% 51
2024
Q3 		$403K Sell
455
-10,817
-96% -$9.73M 0.1% 64
2024
Q2 		$10.2M Sell
11,272
-3,922
-26% -$3.14M 0.53% 45
2024
Q1 		$11.8M Hold
15,194
– – 0.93% 32
2023
Q4 		$8.82M Sell
15,194
-939
-6% -$548K 0.48% 48
2023
Q3 		$8.67M Sell
16,133
-434
-3% -$224K 0.47% 48
2023
Q2 		$7.77M Hold
16,567
– – 0.41% 51
2023
Q1 		$5.69M Buy
16,567
+379
+2% +$128K 0.31% 50
2022
Q4 		$5.92M Hold
16,188
– – 0.35% 47
2022
Q3 		$5.23M Sell
16,188
-155
-0.9% -$49.1K 0.35% 48
2022
Q2 		$5.3M Buy
16,343
+4,128
+34% +$1.24M 0.36% 44
2022
Q1 		$3.5M Buy
12,215
+1,286
+12% +$331K 0.22% 55
2021
Q4 		$3.02M Buy
10,929
+3,998
+58% +$1.01M 0.19% 67
2021
Q3 		$1.6M Sell
6,931
-268
-4% -$66.1K 0.11% 124
2021
Q2 		$1.65M Hold
7,199
– – 0.11% 127
2021
Q1 		$1.34M Sell
7,199
-1,097
-13% -$215K 0.1% 145
2020
Q4 		$1.4M Sell
8,296
-3,146
-27% -$470K 0.11% 129
2020
Q3 		$1.69M Buy
11,442
+4,418
+63% +$684K 0.14% 92
2020
Q2 		$1.15M Buy
+7,024
New +$1.08M 0.14% 71
2019
Q4 		– Sell
-7,866
Closed -$880K – 354
2019
Q3 		$880K Sell
7,866
-6,776
-46% -$754K 0.18% 70
2019
Q2 		$1.62M Sell
14,642
-2,117
-13% -$249K 0.33% 48
2019
Q1 		$2.17M Buy
16,759
+8,121
+94% +$988K 0.37% 39
2018
Q4 		$1M Buy
+8,638
New +$965K 0.25% 57

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Symmetry Partners's LLY Position: Q2 2026 in Review

Symmetry Partners increased its Eli Lilly (LLY) stake by 45% in Q2 2026, buying an estimated $1.05M and bringing the position to 3,325 shares worth $3.99M. The position accounts for 0.2% of the portfolio, ranked #48.

Symmetry Partners first reported a position in LLY in Q4 2018 and has held it in 29 quarters since. The position peaked at $11.8M in Q1 2024. 1,943 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Symmetry Partners held 3,325 shares of Eli Lilly worth $3.99M as of Q2 2026.
  • Symmetry Partners bought 1,031 Eli Lilly shares in Q2 2026, an estimated $1.05M.
  • Eli Lilly made up 0.2% of Symmetry Partners's portfolio in Q2 2026, its #48 holding.
  • Symmetry Partners first reported a position in Eli Lilly in Q4 2018 and has held it in 29 quarters since.
  • Symmetry Partners's Eli Lilly position peaked at $11.8M in Q1 2024.
  • 1,943 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Symmetry Partners's 13F filing for Q2 2026, filed 23 Jul 2026.